|
|
|
| Cell Bank Manufacturing | Your master cell bank (MCB) is critical to therapeutic product development, in addition to supporting clinical development, manufacturing, and commercial supply of biologics. Put your bank in the hands of the experts and get it right the first time. |
|
|
|
|
By Natasha Kehimkar, CEO and founder, Malida Advisors | Friction often comes from unspoken expectations. Before production begins, treat the combined sponsor-CDMO group as one extended team and intentionally make “how we work together” visible. | |
|
|
| Digging Into Manufacturing Priorities For Viral Vectors | Article | Novartis Contract Manufacturing | Addressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies. |
|
|
|
|
|
|
| Mammalian Expression | Case Study | Curia | See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. |
|
|
| Optimizing Outcomes In ADC Manufacturing | Webinar | LOTTE Biologics | As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Technology transfers can make or break an ADC program, with process and analytical knowledge often spread across multiple partners and teams. Join Bioprocess Online for an interactive discussion with experts as they share practical strategies for managing technology transfers, reducing risk, and preventing costly delays in ADC development. Register today for free thanks to sponsors CPC Biotech, Samsung Biologics and MilliporeSigma. |
|
|
| Connect With Bioprocess Online: |
|
|
|